Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
It's what most investors want more than anything else from their stocks. Three Motley Fool contributors think they've ...
SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue viewing our website.Digital subscribers receiveUnlimited access to all stories ...
(Reuters) -BioAge Labs said on Friday it is discontinuing its mid-stage trial studying its experimental drug as a monotherapy and in combination with Eli Lilly's tirzepatide for the treatment of ...
A study published in Nature estimates the economic burden associated with obesity on major US industries to be in excess of $347bn in 2023.
Last week, the Biden administration passed a rule allowing for the government healthcare programs Medicare and Medicaid ...
Morgan Stanley has chosen Eli Lilly (NYSE:LLY) as its top biopharma pick for 2025 and rated another nine names in the space ...
GM sold its stake in an EV battery plant and warned of a $5 billion charge in China. Cargill announced layoffs. Eli Lilly’s ...
A street sign for Wall Street is seen outside the New York Stock Exchange (NYSE) in New York City, New York, U.S., July 19, 2021. REUTERS/Andrew Kelly/File Photo Global stocks advanced as ...
This content is provided by , which may be using cookies and other technologies.To show you this content, we need your permission to use cookies. You can use the buttons below to amend your ...